A Win For VYNE Therapeutics Inc.
VYNE Therapeutics Inc. (VYNE:NASDAQ) jumped higher at $4.38, representing a gain of 39.9%. On Wed, Apr 19, 2023, VYNE:NASDAQ hit a New 2-Week High of $4.38. The stock got featured on our News Catalysts scanner on Wed, Apr 19, 2023 at 09:06 AM in the 'BIOTECH' category. From Wed, Apr 05, 2023, the stock recorded 77.78% Up Days and 70.00% Green Days
The stock spiked on Tue, Jan 10, 2023 at $6.88 with a volume of 1M+.
About VYNE Therapeutics Inc. (VYNE:NASDAQ)
VYNE Therapeutics Inc is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology.
Top 10 Gainers:
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 80.62%
- BIOLASE, Inc. (BIOL:NASDAQ), 43.73%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 39.94%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 38.61%
- Bed Bath & Beyond Inc. (BBBY:NASDAQ), 34.46%
- SAI.TECH Global Corp Cl A Ord (SAI:NASDAQ), 33.47%
- Getaround Inc. (GETR:NYSE), 32.2%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 31.5%
- Boqii Holding Limited American Depositary Shares representing Class A (BQ:NYSE), 29.51%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 29.11%